Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines
Public ClinicalTrials.gov record NCT04529538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A First-in-human, Phase 1, Randomized, Observer-blind, Controlled Study to Assess the Safety and Immunogenicity of Novel Live Attenuated Type 1 and Type 3 Oral Poliomyelitis Vaccines in Healthy Adults
Study identification
- NCT ID
- NCT04529538
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- PATH
- Other
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Interventions
- Novel Oral Polio Vaccine Type 1 (nOPV1) Biological
- Novel Oral Polio Vaccine Type 3 (nOPV3) Biological
- Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1) Biological
- Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 25, 2021
- Primary completion
- Feb 16, 2023
- Completion
- Feb 16, 2023
- Last update posted
- Nov 19, 2024
2021 – 2023
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pharmaron CPC, Inc. | Baltimore | Maryland | 21201 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| University of North Carolina Institute for Global Health and Infectious Diseases (IGHID) | Chapel Hill | North Carolina | 27599-7215 | — |
| University of Vermont Vaccine Testing Center | Burlington | Vermont | 05405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04529538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04529538 live on ClinicalTrials.gov.